Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Splicing Modulation Results in Aberrant Isoforms and Protein Products of p53 Pathway Genes and the Sensitization of B Cells to Non-Genotoxic MDM2 Inhibition

26 Jan 2023

Abstract excerpt

Several molecular subtypes of cancer are highly dependent on splicing for cell survival. There is a general interest in the therapeutic targeting of splicing by small molecules. E7107, a first-in-class spliceosome inhibitor, showed strong growth inhibitory activities against a large variety of human cancer xenografts. Chronic lymphocytic leukaemia (CLL) is a clinically heterogeneous hematologic malignancy, with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related Molecular Pathways
Share to Chronic Lymphocytic Leukemia Research
Share to Lymphoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36768733
DOI: 10.3390/ijms24032410

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Splicing Modulation Results in Aberrant Isoforms and Protein Products of p53 Pathway Genes and the Sensitization of B Cells to Non-Genotoxic MDM2 InhibitionPMID 36768733Read ↗

Splicing modulation sensitizes chronic lymphocytic leukemia cells to venetoclax by remodeling mitochondrial apoptotic dependenciesSemantic proximity Read ↗

The role of alternative splicing in cancer: From oncogenesis to drug resistance.Semantic proximity Read ↗

Targeting the spliceosome in chronic lymphocytic leukemia with the macrolides FD-895 and pladienolide-B.Semantic proximity Read ↗

Pre-mRNA splicing in cancer: the relevance in oncogenesis, treatment and drug resistance.Semantic proximity Read ↗

Molecular mechanisms by which splice modulator GEX1A inhibits leukaemia development and progression.Semantic proximity Read ↗

RNA Splicing: Basic Aspects Underlie Antitumor Targeting.Semantic proximity Read ↗

Therapeutic targeting of splicing in cancer.Semantic proximity Read ↗

Proteomics Profiling of CLL Versus Healthy B-cells Identifies Putative Therapeutic Targets and a Subtype-independent Signature of Spliceosome DysregulationSemantic proximity Read ↗

Conserved sequence elements in the final exon of MDM2-eight-exon skipping event reveal a ‘cassette regulon’ model of alternative splicing controlled by a distal regulatory elementSemantic proximity Read ↗

Posttranslational Regulation of the Exon Skipping Machinery Controls Aberrant Splicing in LeukemiaSemantic proximity Read ↗

Acquired mutations that affect pre-mRNA splicing in hematologic malignancies and solid tumors.Semantic proximity Read ↗

Therapeutic Modulation of RNA Splicing in Malignant and Non-Malignant DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.